A Randomized, Double-Blind, Placebo-Controlled Study of the Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

注册号:

Registration number:

ChiCTR-TRC-05000734 

最近更新日期:

Date of Last Refreshed on:

2015-06-04 14:12:15 

注册时间:

Date of Registration:

2005-09-26 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

A Randomized, Double-Blind, Placebo-Controlled Study of the Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

Public title:

A Randomized, Double-Blind, Placebo-Controlled Study of the Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

注册题目简写:

English Acronym:

研究课题的正式科学名称:

A Randomized, Double-Blind, Placebo-Controlled Study of the Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

Scientific title:

A Randomized, Double-Blind, Placebo-Controlled Study of the Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

CUHK_CCT00084

申请注册联系人:

Hon KL 

研究负责人:

Christy Kam 

Applicant:

Hon KL 

Study leader:

Christy Kam 

申请注册联系人电话:

Applicant telephone:

Nil

研究负责人电话:

Study leader's
telephone:

Nil

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

nil@msn.com

研究负责人电子邮件:

Study leader's E-mail:

nil@msn.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

http://www.cct.cuhk.edu.hk/registry/publictrialrecord.aspx?trialid=CUHK_CCT00084

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

http://www.cct.cuhk.edu.hk/registry/publictrialrecord.aspx?trialid=CUHK_CCT00084

申请注册联系人通讯地址:

Departmetn of Paediatrics

研究负责人通讯地址:

Departmetn of Paediatrics

Applicant address:

Departmetn of Paediatrics

Study leader's address:

Departmetn of Paediatrics

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

Departmetn of Paediatrics

Applicant's institution:

Departmetn of Paediatrics

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

NA

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Chinese University of Hong Kong

Name of the ethic committee:

Chinese University of Hong Kong

伦理委员会批准日期:

Date of approved by ethic committee:

2001-04-11 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

Department of Paediatrics

Primary sponsor:

Department of Paediatrics

研究实施负责(组长)单位地址:

Department of Paediatrics

Primary sponsor's address:

Department of Paediatrics

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中國

省(直辖市):

香港特別行政區

市(区县):

Country:

China

Province:

Hong Kong SAR

City:

单位(医院):

Institute of Chinese Medicine

具体地址:

Institute of Chinese Medicine

Institution
hospital:

Institute of Chinese Medicine

Address:

Institute of Chinese Medicine

经费或物资来源:

HHSRF

Source(s) of funding:

HHSRF

研究疾病:

Skin and Connective Tissue Diseases  

Target disease:

Skin and Connective Tissue Diseases

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children  

Objectives of Study:

Therapeutic Effect and Safety of a Traditional Chinese Medicine (TCM) for Atopic Dermatitis in Children

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

active asthma oral steroids G6PDD

Exclusion criteria:

active asthma oral steroids G6PDD

研究实施时间:

Study execute time:

From 2004-10-01 00:00:00 To 2012-09-05 00:00:00  

征募观察对象时间:

Recruiting time:

From 2004-10-01 00:00:00 To 2012-09-05 00:00:00

干预措施:

Interventions:

组别:

Two groups

样本量:

80

Group:

Two groups

Sample size:

干预措施:

Use of TCM formulation 12 weeks versus placebo

干预措施代码:

Intervention:

Use of TCM formulation 12 weeks versus placebo

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中國

省(直辖市):

香港特別行政區 

市(区县):

 

Country:

China

Province:

Hong Kong SAR

City:

单位(医院):

Department of Paediatrics 

单位级别:

Institution
hospital:

Department of Paediatrics

Level of the institution:

H

测量指标:

Outcomes:

指标中文名:

SCORA

指标类型:

主要指标

Outcome:

SCORA

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

steroid sue antihistamine use chemokine markers

指标类型:

次要指标

Outcome:

steroid sue antihistamine use chemokine markers

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Random

Randomization Procedure (please state who generates the random number sequence and by what method):

Random

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

Open label

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2015-06-04 14:12:15